Alzheimers disease therapeutics companion diagnostics - AltPep
Alternative Names: SOBA-AD; Soluble Oligomer Binding Assay - Alzheimers diseaseLatest Information Update: 07 Mar 2022
Price :
$50 *
At a glance
- Originator University of Washington
- Developer AltPep Corporation
- Class Diagnostic agents
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preclinical Alzheimer's disease